About this data

The News' COVID-19 dashboard is based on data from the Yale COVID-19 Statistics webpage, which reflects data for both Yale's asymptomatic testing program as well as tests given to symptomatic students. Yale's data is generally delayed by two to three days, and the News updates our dashboard each time Yale publicly releases its latest counts. Yale has de-duplicated these numbers so that students who test positive multiple times are only counted the first time, and so that total tests given reflects the number of unique individuals tested on a single day. The News' data begins on January 8th, 2021.

Visualizations by Omar Chishti and Daniel Kim.

Read the News' latest reporting

SIMONA HAUSLEITNER

Yale study finds global wealth disparities lead to inequities in vaccine access

A recent study conducted by researchers at the Yale School of Medicine reveals that high-income countries have received greater access to COVID-19 vaccines than low- and middle-income countries, likely due to failures in vaccine delivery and a tendency of private vaccine manufacturers to prioritize nations that can pay a higher premium for doses.

December 7, 2021

NATALIE MAKABLEH

COVID-19 nasal spray vaccine in the works at Yale

A new Yale study is investigating the use and effectiveness of a potential nasal vaccine technology that could help put an end to the pandemic.

December 7, 2021

SOPHIE WANG & AISLINN KINSELLA

First case of Omicron COVID-19 variant detected in Connecticut

The first case of the Omicron variant has been reported in the state of Connecticut. Health care experts believe there are more cases in Connecticut which have not yet been detected.

December 6, 2021

ABE BAKER-BUTLER

Yale scientist co-chairs Lancet Commission, publishes vaccine hesitancy report

A new Yale co-led report in The Lancet examines the current state of COVID-19 vaccine refusal and acceptance, as well as strategies for addressing vaccine hesitancy in the United States.

December 2, 2021

AISLINN KINSELLA

Yale scientists identify remdesivir resistance in immunocompromised COVID-19 patient

Researchers at the Yale School of Public Health and the School of Medicine identified a SARS-CoV-2 remdesivir resistance mutation in an immunocompromised patient.

December 2, 2021

HANNAH QU

COVID-19 cases rise in Yale and New Haven

In recent weeks, COVID-19 cases have steadily risen within Yale University and the greater New Haven area.

December 1, 2021

SOPHIE WANG

YNHH hospitalized COVID-19 patients double, 90 percent unvaccinated

Yale New Haven Hospital revealed that 90 percent of hospitalized COVID-19 patients did not receive the COVID-19 vaccine.

December 1, 2021

AISLINN KINSELLA

Yale experts weigh in on how inequitable vaccine rollout may have allowed for Delta variant and cost human lives

COVID-19 has exacerbated existing inequities in global health, with an especially high toll on developing countries.

November 12, 2021

JASMINE SU

Emphasizing that vaccines protect others can encourage COVID-19 vaccination, Yale study finds

According to a Yale study, it is more effective to tell people that vaccines protect others than that vaccines protect their own health.

November 10, 2021

SOPHIE WANG

FDA authorizes SalivaDirect for pooled COVID-19 testing

SalivaDirect, a COVID-19 test developed at the Yale School of Public Health, receives FDA approval for pooled testing.

November 9, 2021

MAYA WEITZEN

Children aged 5-11 are now eligible for COVID-19 vaccinations

The Connecticut governor and public health commissioner issued a press release announcing that children aged 5-11 can now receive COVID-19 vaccinations following recent FDA recommendations.

November 9, 2021